Home
Graduate Program
Genetic Counselling
Research
Clinical Genetics
Events/Awards
Resources

Zoe Lohn

Thursday, July 22nd, 2010, 9:00am. Rm. 226 Michael Smith Laboratories

“A New Role for the Tumour Suppressor, lin-35, During Meiotic Recombination in Caenorhabditis elegans

Zoe Lohn defense programme (pdf)

 

EXAMINING COMMITTEE

Chair: Dr. Rob Kay (Medical Genetics)

Supervisory Committee: Dr. Ann Rose, Research Supervisor (Medical Genetics), Dr. Hugh Brock (Genetics)

University Examiner: Dr. Stefan Taubert (Medical Genetics)

 

SUPERVISORY COMMITTEE

Dr. Ann Rose, Dr. Don Riddle & Dr. Hugh Brock

           

ABSTRACT

            Meiosis is a fundamental biological process used by sexually reproducing species to ensure the faithful transmission of genetic material.  In humans, failure to recombine properly during meiosis causes genetic conditions in the human conceptus such as aneuploidy and spontaneous abortion.

            An excellent model organism for the investigation of meiotic recombination is the nematode, Caenorhabditis elegans, which has many conserved meiotic processes. In this thesis, I have investigated the role of LIN-35 in meiotic crossing over. LIN-35 is the C. elegans ortholog of the retinoblastoma protein, well characterized with respect to its role in gene transcription and cell proliferation.  My results show that mutation in the lin-35 gene alters recombination frequency differentially for several regions of the chromosome, causing increases in recombinationally suppressed regions and decreases in highly recombinogenic regions.  In combination with Rec-1, a mutant known to alter crossover distribution, crossovers across the length of the entire chromosome, were decreased.  In addition, other severely detrimental phenotypes were observed.  For example, gametic viability was reduced dramatically in the double mutant, compared to either mutant alone. Thus, Lin-35 and Rec-1 are synergistic, indicating that they act in different pathways.  In summary, Lin-35 function plays a role in achieving normal levels of meiotic recombination, a role that may be related to its function in chromatin modification and gene transcription.

 

BIOGRAPHICAL NOTES

Born: November 20th 1986, Vancouver, British Columbia

Academic Studies: B.Sc. Queen’s University, 2008

Current Position: MSc candidate, University of British Columbia

 

GRADUATE STUDIES

Field of Study: Medical Genetics

Courses:           

MEDG 419: Human Cytogenetics, Dr. Carolyn Brown

MEDG 520: Advances in Human Molecular Genetics, Dr. Matthew Lorincz

MEDG 530: Human Genetics, Dr. Jan Friedman

MEDG 535: Genetics and Ethics, Dr. Anita Ho

MEDG 545: Current Topics in Medical Genetics Research, Dr. Carolyn Brown

MEDG 548: Directed Studies, Dr. Ann Rose

MEDG 549: Thesis Course, Dr. Ann Rose

 

AWARDS

Entrance Scholarship, Genetic Counselling Program, UBC (2010)

Dean’s Honours Award, Queen’s University (2008)

 

PUBLICATIONS

Jones M, Lohn Z and Rose A. “Specialized Chromosomes” Methods in Cell Biology. (In Press)

 

PRESENTATIONS

Lohn Z and Rose A. A new role for the tumour suppressor, lin-35, in meiotic recombination in C. elegans. (Poster) UBC Department of Medical Genetics Research Day. November 6th 2009.

Lohn Z and Rose A. Do chromatin modifiers affect the meiotic pattern in C. elegans? (Poster) Canadian Human Genetics Conference, Harrison Hot Springs, BC, Canada. May 24th-27th 2009.

Zoe Lohn Defense Programme (pdf)